NR Longevity

product on market Capsule Pure Encapsulations Safety: 87/100
87/100

This product is generally safe

  • Nicotinamide Riboside Chloride: 300mg is 8.6× the Tolerable Upper Intake Level (35mg)
  • 67% of ingredients have research evidence
C Label Compliance Grade

What the Evidence Says

AI-generated · Qwen 3.6 · methodology

Nicotinamide riboside and trans-resveratrol are studied for their roles in NAD+ restoration and cellular health, though clinical evidence remains moderate. Broccoli sprout concentrate provides sulforaphane to support antioxidant pathways. Overall, these ingredients are generally well-tolerated with a high safety score.

AI-generated summary based on research evidence. Not medical advice.

Alerts

Safety Alerts

Nicotinamide Riboside Chloride: 300mg is 8.6× the Tolerable Upper Intake Level (35mg)

Label

Product Label

Label for NR Longevity
Open Full PDF View on NIH DSLD →
Details

Label Data

2 Capsule(s)
Serving Size
30
Servings
Other Combinations
Product Type
67%
Evidence Coverage
Ingredients

Supplement Facts — Evidence Check

Exceeds UL by 8.6× (UL: 35 mg) 196 studies (A:5, B:63)
Broccoli Sprout, Whole Plant Concentrate
200 mg
Market median: 167.0mg (311 products) 183 studies (A:0, B:65)

Other Ingredients

Cellulose Water Plant Fiber Rice Bran Extract Rice Gum Arabic Sunflower Oil
Claims

Label Claims — Verification

Unverified Nutrient
Unverified All Other
Unverified Structure/Function
Info

Product Information

Directions for Use

Recommendations: As a dietary supplement, take 2 capsules, 1-2 times daily, with or between meals, or as directed by a health professional.

Warnings & Precautions

Warning: If you are pregnant or lactating, have any health condition or are taking any medication, consult your health professional before use.

Keep out of the reach of children.

Use only if safety seal is intact.

Formulation Notes

Certified Gluten-Free by the Gluten-Free Certification Organization, www.gluten.org

NR Longevity with NIAGEN nicotinamide riboside; decreases the effects of cellular aging

Gluten-free, non-GMO & hypoallergenic

Gluten-free, non-GMO & hypoallergenic

Powered by Niagen

Additional Information

Store in a cool, dry place.

Contents may not fill package in order to accommodate required labeling. Please rely on stated quantity.

GFCO.org (Gluten-Free Certification Organization)

Scan to learn about our hypoallergenic supplements

Metadata

Product Details

UPC / SKU7 66298 02580 3
DSLD Entry Date2024-09-25
Product TypeOther Combinations
FormCapsule
DSLD ID313541
Data Updated2026-04-11
Research

Research Evidence

10
Research Sources
49
Avg Quality
8
Rct
1
Systematic Review
1
Clinical Trial
B Chronic nicotinamide riboside supplementation is well-tolerated and elevates NAD+ in healthy middle-aged and older adults
Rct Nature communications 2018 PubMed DOI
C The effects of NAD+ precursor (nicotinic acid and nicotinamide) supplementation on weight loss and related hormones: a systematic review and meta-regression analysis of randomized controlled trials
Systematic Review Frontiers in nutrition 2023 PubMed DOI
C Effect of nicotinamide riboside on airway inflammation in COPD: a randomized, placebo-controlled trial.
Rct Nature aging PubMed DOI
C Safety and Metabolism of Long-term Administration of NIAGEN (Nicotinamide Riboside Chloride) in a Randomized, Double-Blind, Placebo-controlled Clinical Trial of Healthy Overweight Adults
Rct Scientific reports 2019 PubMed DOI
C Nicotinamide Riboside Augments the Aged Human Skeletal Muscle NAD+ Metabolome and Induces Transcriptomic and Anti-inflammatory Signatures
Rct Cell reports 2019 PubMed DOI
C Oral nicotinamide riboside raises NAD+ and lowers biomarkers of neurodegenerative pathology in plasma extracellular vesicles enriched for neuronal origin
Rct Aging cell 2023 PubMed DOI
C Nicotinamide riboside with pterostilbene (NRPT) increases NAD+ in patients with acute kidney injury (AKI): a randomized, double-blind, placebo-controlled, stepwise safety study of escalating doses of NRPT in patients with AKI
Rct BMC nephrology 2020 PubMed DOI
C Clinical Trial of Niagen to Examine Recovery in People With Persistent Cognitive and Physical Symptoms After COVID-19
Clinical Trial ClinicalTrials.gov 2021
C A randomized placebo-controlled trial of nicotinamide riboside and pterostilbene supplementation in experimental muscle injury in elderly individuals.
Rct JCI insight PubMed DOI
C Nicotinamide Riboside Supplementation Benefits in Patients With Werner Syndrome: A Double-Blind Randomized Crossover Placebo-Controlled Trial.
Rct Aging cell PubMed DOI
View all evidence for Nicotinamide Riboside →
Compare

Similar Products

View all Nicotinamide Riboside products →

This product page is for informational purposes only and does not constitute medical advice. Always consult your healthcare provider before taking any supplement.